Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome
Authors:
- Peter L. HavensPHPeter L. Havens
- Owen W. GriffithOGOwen W. Griffith
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 25 (6) , 1071-1078
Abstract
The systemic inflammatory response syndrome (SIRS) is typified by the presence of fever, hemodynamic changes, and end organ dysfunction. Endothelial cell activation leads to overproduction of nitric oxide, which results in sustained vasodilation and hypotension. This study was undertaken to determine the sensitivity, specificity, and positive and negative predictive values of plasma nitrite/nitrate measurements in identifying patients with clinical characteristics of SIRS, as defined by criteria based on physician diagnosis. Prospective cohort study with consecutive sampling of patients. Tertiary, multidisciplinary, pediatric intensive care unit (ICU) at Children's Hospital of Wisconsin. Patients were divided into five groups. There were 16 pediatric controls undergoing elective surgery and 177 pediatric ICU patients without and 46 pediatric ICU patients with physician-diagnosed sepsis, septic shock, SIRS, or sepsis syndrome documented in the medical record (all considered physician-diagnosed sepsis). The 223 pediatric ICU patients included 195 pediatric ICU patients not meeting and 28 pediatric ICU patients meeting predetermined physiologic criteria for SIRS (considered criteria-based sepsis). Blood samples were obtained for quantitative nitrite/nitrate analysis at the time of admission to the pediatric ICU and daily until discharge. Mean plasma nitrite/nitrate concentrations in the controls were 34.5 +/- 12 micro M (95th percentile 54 micro M). In pediatric ICU patients without and with physician-diagnosed sepsis, mean plasma nitrite/nitrate concentrations were 39 +/- 24 micro M (p > .05 compared with controls) and 127 +/- 91 micro M (p < .0001 compared with both controls and patients without physician-diagnosed sepsis), respectively. In pediatric ICU patients without and with criteria-based sepsis, the mean total plasma nitrite/nitrate concentrations were 56 +/- 59 micro M (p = .008 compared with controls) and 80 +/- 64 micro M (p = .003 compared with patients without criteria-based sepsis), respectively. The ability of plasma nitrite/nitrate >54 micro M to identify patients with physician-diagnosed sepsis is characterized as follows: 87% sensitivity, 77% specificity, 50% positive predictive value, and 96% negative predictive value. The ability of plasma nitrite/nitrate >54 micro M to identify patients with criteria-based sepsis is characterized as follows: 61% sensitivity, 68% specificity, 21% positive predictive value, and 92% negative predictive value. Clinical diagnosis of SIRS is strongly associated with increased total plasma nitrite/nitrate concentrations in pediatric patients in the pediatric ICU. Many patients with increased nitrite/nitrate concentrations have inflammation without having a clinical diagnosis of SIRS. Our data suggest that increased plasma nitrite/nitrate concentrations are the standard for identifying patients with inflammation in the pediatric ICU. (Crit Care Med 1997; 25:1071-1078)Keywords
This publication has 16 references indexed in Scilit:
- Nitric Oxide Synthases: Properties and Catalytic MechanismAnnual Review of Physiology, 1995
- Plasma nitric oxide levels in newborn infants with sepsisThe Journal of Pediatrics, 1993
- Overproduction of Nitric Oxide in Cytokine-Mediated and Septic ShockJNCI: Journal of the National Cancer Institute, 1992
- The Role of Nitric Oxide in Endotoxic Shock: Effects of NG-Monomethyl-L-ArginineJournal of Cardiovascular Pharmacology, 1992
- Nitrogen Oxide Levels in Patients After Trauma and During SepsisAnnals of Surgery, 1991
- Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesisBiochemical and Biophysical Research Communications, 1990
- Endothelial Cell Production of Nitrogen Oxides in Response to Interferon in Combination With Tumor Necrosis Factor, Interleukin-1, or EndotoxinJNCI: Journal of the National Cancer Institute, 1990
- NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.Proceedings of the National Academy of Sciences, 1990
- NG-methylarginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo?Biochemical and Biophysical Research Communications, 1989
- Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide.Proceedings of the National Academy of Sciences, 1985